Advertisement

Crimson staff writer

Claire Yuan

Latest Content

University Hall
College

Phi Beta Kappa Inducts Class of 2022 ‘Senior 48’

Forty-eight seniors learned Monday that they had been inducted into the Harvard chapter of the Phi Beta Kappa honor society, joining the “Junior 24” selected in the spring.

Benjamin P. Wenzelberg
Conversations

A 96-Minute, 417-Page Senior Thesis

If you had visited Buckminster’s Cafe in the early mornings this past year, you would have passed super senior Benjamin P. “Benjy” Wenzelberg 21-'22 composing an opera. As a joint concentrator in English and Theater, Dance and Media, Wenzelberg’s senior thesis is an opera adaptation of James Joyce’s “Ulysses.”

IOP President and Vice President
IOP

IOP Elects First Palestinian-American President and All Women of Color Executive Board

The IOP will be led by its first Palestinian-American President and first all women of color executive board.

Research

Harvard Inks $30M Deal with Pharmaceutical Company for Therapeutic Research

Harvard University has signed a new five-year research and development agreement with pharmaceutical company National Resilience, Inc. to advance the development of medical technologies including gene, stem cell, and nucleic acid therapies.

Pierce Hall
Research

On the Cusp: SEAS Researchers Investigate Why Apples Have Dimples

Though seemingly mundane apple morphology rarely concerns even the most curious of scholars, Mahadevan had been musing over this particular concept for nearly a decade before it bore fruit.

Chan School of Public Health
Research

Harvard Researchers Declare ‘Structural Change’ Needed to Address Planetary Health Crisis

Harvard researchers outlined lifestyle changes that would need to occur on a societal level to optimize the health and well-being of the general population and the planet in a declaration in The Lancet on Tuesday.

Biostasis
The Scoop

Taking Vaccination from Needle to Chip

With a one-year grant from the federal government’s Biomedical Advanced Research and Development Authority, the Wyss Institute has become one of three participants in the ImmuneChip+ Program.

Advertisement